Successful Treatment of Chronic Inflammatory Enteropathy in 2-Year-Old Yorkshire Terier. Case Report

Chronic enteropathy in dogs represents a significant clinical challenge that often requires innovative therapeutic strategies for effective management. This case study investigated the simultaneous use of budesonide, cannabidiol (CBD) oil and probiotics. Budesonide represents a corticoid therapy pri...

Full description

Saved in:
Bibliographic Details
Published in:Folia Veterinaria 2024-12, Vol.68 (4), p.62-69
Main Authors: Kunay, Lukáš, Kožár, Martin, Fialkovičová, Mária, Horňák, Slavomír, Kacková, Gabriela, Figurová, Mária
Format: Article
Language:English
Subjects:
budesonide
cannabidiol oil
chronic enteropathy
diarrhoea
probiotics
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Chronic enteropathy in dogs represents a significant clinical challenge that often requires innovative therapeutic strategies for effective management. This case study investigated the simultaneous use of budesonide, cannabidiol (CBD) oil and probiotics. Budesonide represents a corticoid therapy primarily used in human medicine for autoimmune diseases. Cannabidiol oil is one of the cannabinoids that does not affect sensory perception and is known for its anti-inflammatory properties. Probiotics help maintain gut microbiota balance as a treatment modality for chronic enteropathy in dogs. This report details the clinical symptoms, diagnosis, and treatment plan, highlighting the positive response seen in the patient. The findings suggested that the combination of budesonide, CBD oil, and probiotics may be a beneficial strategy for the treatment of chronic enteropathy in dogs.
ISSN:0015-5748
2453-7837
DOI:10.2478/fv-2024-0040